ES459479A1 - Clavulanic acid derivatives - Google Patents

Clavulanic acid derivatives

Info

Publication number
ES459479A1
ES459479A1 ES459479A ES459479A ES459479A1 ES 459479 A1 ES459479 A1 ES 459479A1 ES 459479 A ES459479 A ES 459479A ES 459479 A ES459479 A ES 459479A ES 459479 A1 ES459479 A1 ES 459479A1
Authority
ES
Spain
Prior art keywords
formula
acid derivatives
carboxylic acid
free carboxylic
exchangeable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES459479A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of ES459479A1 publication Critical patent/ES459479A1/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Clavamic acid derivatives of the formula < IMAGE > in which R is -NH2 and R<3> is -COOH or an esterified carboxyl group, are prepared from corresponding azides, R = -N3 in the above formula, by reduction. The free carboxylic acid can be in the form of a zwitterion or a salt with acids or bases it can be esterified. The starting material with R = -N3 is advantageously prepared from an ester of the formula II in which R is an exchangeable atom or an exchangeable group by reaction with an azide. The products (II), especially the free carboxylic acid, have antibacterial activity on various Gram-negative and Gram-positive microorganisms and they inhibit beta -lactamase they can be used alone as antibiotics or in combination with beta -lactam antibiotics for the treatment of infectious diseases.
ES459479A 1976-06-04 1977-06-03 Clavulanic acid derivatives Expired ES459479A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB23268/76A GB1585124A (en) 1976-06-04 1976-06-04 Clavulanic acid derivatives

Publications (1)

Publication Number Publication Date
ES459479A1 true ES459479A1 (en) 1978-11-16

Family

ID=10192928

Family Applications (2)

Application Number Title Priority Date Filing Date
ES459479A Expired ES459479A1 (en) 1976-06-04 1977-06-03 Clavulanic acid derivatives
ES470333A Expired ES470333A1 (en) 1976-06-04 1978-05-30 Clavulanic acid derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES470333A Expired ES470333A1 (en) 1976-06-04 1978-05-30 Clavulanic acid derivatives

Country Status (15)

Country Link
JP (1) JPS5321193A (en)
AT (1) AT356814B (en)
AU (1) AU517897B2 (en)
BE (1) BE855375A (en)
CH (1) CH628055A5 (en)
DE (1) DE2725203A1 (en)
DK (1) DK247877A (en)
ES (2) ES459479A1 (en)
FI (1) FI771772A (en)
FR (1) FR2353556A1 (en)
GB (1) GB1585124A (en)
IL (1) IL52244A0 (en)
NL (1) NL7706119A (en)
SE (1) SE7706518L (en)
ZA (1) ZA773348B (en)

Families Citing this family (8)

* Cited by examiner, ā€  Cited by third party
Publication number Priority date Publication date Assignee Title
GB1604822A (en) * 1977-04-22 1981-12-16 Beecham Group Ltd N-monosubstituted-9-amino-9-deoxyclavulanic acid derivative
FR2388814A1 (en) * 1977-04-27 1978-11-24 Beecham Group Ltd 9-Amino-de:oxy-clavulanic acid and acylated derivs. - antibacterials and beta-lactamase inhibitors
JPS54117459A (en) * 1978-01-20 1979-09-12 Glaxo Group Ltd Novel lactam compound
EP0028083B1 (en) * 1979-10-26 1984-02-08 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and pharmaceutical compositions containing them
NZ199061A (en) * 1980-12-09 1984-10-19 Beecham Group Ltd 9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
EP0068609A1 (en) * 1981-06-11 1983-01-05 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and their use
GB8521516D0 (en) * 1985-08-29 1985-10-02 Beecham Group Plc Compounds
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
ES470333A1 (en) 1979-01-01
FR2353556A1 (en) 1977-12-30
CH628055A5 (en) 1982-02-15
DE2725203A1 (en) 1977-12-22
DK247877A (en) 1977-12-05
SE7706518L (en) 1978-01-23
NL7706119A (en) 1977-12-06
FR2353556B1 (en) 1980-04-04
BE855375A (en) 1977-12-05
AU2580477A (en) 1978-12-07
AU517897B2 (en) 1981-09-03
ZA773348B (en) 1978-06-28
AT356814B (en) 1980-05-27
JPS6135994B2 (en) 1986-08-15
JPS5321193A (en) 1978-02-27
FI771772A (en) 1977-12-05
ATA395477A (en) 1979-10-15
IL52244A0 (en) 1977-08-31
GB1585124A (en) 1981-02-25

Similar Documents

Publication Publication Date Title
IE45003L (en) Oxiranylmethyltetrahydropyran derivatives
GB1348199A (en) Acylaminopenicillanic acid derivatives
IE831527L (en) Preparation of azetidinooxazole derivatives
IE45015L (en) Cephalosporin derivatives.
ES463974A1 (en) Process for manufacture of 9-amino-9-deoxyclavulanates
ES470333A1 (en) Clavulanic acid derivatives
FR2272684A1 (en) Antibiotic-unsaturated acid compsns. - having a synergistic effect against gram positive and negative bacteria
ES455404A1 (en) Therapeutic compounds containing beta -lactams
ES8106531A1 (en) Polyazathia compounds, process for their preparation, pharmaceutical preparations containing such compounds and use of the latter.
JPS57203087A (en) Production of antibacterial
GB1531141A (en) Beta-lactam antibiotics
ES8503001A1 (en) 1,1-Alkanediol dicarboxylate linked antibacterial agents.
IE800429L (en) Penicillanic acid 1,1-dioxides
ES471964A1 (en) Process for the preparation of alpha-substituted-thien-3-ylacetic acid and derivatives thereof.
EP0003415A3 (en) Beta-lactam compounds, processes for their preparation,compositions containing them and intermediates of use in their preparation
IE44607L (en) Cephalosporin compounds.
GB1530872A (en) Derivatives of 7-(2-amino-4-thiazolylacetamido)-cephalosporanic acid processes for preparing them and pharmaceutical compositions containing them
JPS5646885A (en) Novel cephamycin ester and its preparation
SE7416387L (en)
ES424204A1 (en) 1-oxadethiapenicillanic acid derivatives
GB1512660A (en) Cephalosporin esters
IE46100L (en) Clavulanic acid derivatives
ES8500957A1 (en) Cephalosporin compounds.
GB1389195A (en) Antibiotics
IE42666L (en) Deoxyclavulanic acid and deoxyisoclavulanic acid andĀ¹derivatives thereof